Details for 2017705236

Up to date per 07.04.2026

Actions

Title / Product Name

OPTIMIERTE FAKTOR-VIII-GENE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017705236

EP Publication Number

3411478

E-Number

1496945

Language

PCT Number

US17015879

Publication Date

12.12.2018 A

08.06.2022 B1

Registration Date

08.06.2022

AT Publication Date

15.06.2022

Application Date

31.01.2017

Registration Number

Priorities

01.02.2016

201662289696 P

18.10.2016

201662409739 P

IPC

C12N 9/64 20060101AFI20170831BHEP

Maximum Duration of Protection

31.01.2037

Owner

Bioverativ Therapeutics Inc.225 Second Avenue Waltham, MA 02451US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

TAN, Siyuan53 Buckman Drive Lexington, Massachusetts 02421US

LIU, Tongyao53 Buckman Drive Lexington, Massachusetts 02421US

Information about Fees